Ipilimumab/nivolumab/tozinameranImmune reaction and adrenal insufficiency: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1902卷 / 1期

关键词：

D O I：

10.1007/s40278-022-13401-9

中图分类号：

学科分类号：

摘要：

引用

页码：257 / 257

共 50 条

[21] Ipilimumab/nivolumabHypothyroidism, adrenal insufficiency and type I diabetes mellitus: case report
Reactions Weekly, 2020, 1795 (1) : 163 - 163
[22] Ipilimumab/nivolumabHypophysitis and adrenal insufficiency following off label use: case report
Reactions Weekly, 2019, 1781 (1) : 207 - 207
[23] Secondary adrenal insufficiency due to ipilimumab/nivolumab treatment for metastatic renal cancer
Rico-Lopez, D.
Ortiz-Parra, A.
Vazquez-Alonso, F.
Roa-Chamorro, R.
REVISTA CLINICA ESPANOLA, 2025, 225 (02):
[24] A case with a primary adrenal insufficiency secondary to nivolumab
Coskun, Nur Sinem Sengoz
Simsir, Ilgin Yildirim
Goksel, Tuncay
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[25] Ipilimumab/nivolumab/pembrolizumabImmune-mediated central adrenal insufficiency and seronegative encephalitis
Reactions Weekly, 2024, 2016 (1) : 258 - 258
[26] Ipilimumab/nivolumab/nivolumab/pembrolizumabType 1 diabetes: case report
Reactions Weekly, 2023, 1956 (1) : 286 - 286
[27] Lichenoid drug reaction after ipilimumab/nivolumab combination therapy: A case report
Moore, Zonia Robenne
Zajdman-Faitelson, Dalit
Campillo, Arely Tamariz
Bustillos, Diana Karen Brito
Toussaint-Caire, Sonia
Berumen-Glinz, Cristina
SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
[28] Ipilimumab/nivolumab/sorafenibSarcoidosis-like reaction and lack of efficacy: case report
Reactions Weekly, 2023, 1980 (1) : 221 - 221
[29] Ipilimumab/nivolumabAdrenal insufficiency: case report
Reactions Weekly, 2020, 1828 (1) : 285 - 285
[30] Ipilimumab/nivolumabAdrenal insufficiency: case report
Reactions Weekly, 2023, 1973 (1) : 148 - 148

← 1 2 3 4 5 →